Cognition Therapeutics, Inc. (NASDAQ:CGTX) Q2 2024 Earnings Conference Call August 11, 2024 8:30 AM ET

Company Participants

Thomas Johnson - Director, Corporate Communications, LifeSci Advisors, LLC
Lisa Ricciardi - Chief Executive Officer
John Doyle - Chief Financial Officer
Anthony Caggiano - Chief Medical Officer, Head of R&D

Conference Call Participants

Charles Duncan - Cantor Fitzgerald
Raghuram Selvaraju - H.C. Wainwright
Daniil Gataulin - Chardan

Operator

Hello, and thank you for standing by. At this time, I would like to welcome you to the Cognition Therapeutics Second Quarter 2024 Earnings Call. All lines has been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions].

I would now like to turn the conference over to Tom Johnson. Please go ahead.

Thomas Johnson

Thank you, operator, and good morning, everyone. Welcome to the Cognition Therapeutics second quarter 2024 results conference call. With me today are Lisa Ricciardi, President and Chief Executive Officer; John Doyle, Chief Financial Officer; and Tony Caggiano, Chief Medical Officer.

This morning, the company issued a press release detailing its financial results for the second quarter and first half of the 2024 fiscal year. We encourage everyone to read this morning's press release as well as Cognition's' quarterly report on Form 10-Q, annual report on Form 10-K and periodic reports on Form 8-K, which are now filed with the SEC and available on our website. In addition, this conference call is being webcast through the company's website and will be archived for 30 days.

Please note that certain information discussed on the call today is covered by the safe harbor provisions of the Private Securities Litigation Reform Act. We caution listeners that during this call, management will be making forward-looking statements. Actual results could differ materially from those stated or implied by these forward-looking statements due to risks and uncertainties associated with the company's business. These forward-looking statements are qualified by cautionary statements contained in the Cognition press release and SEC filings, including its quarterly report on Form 10-Q and previous filings.

This conference call contains time sensitive information, which is accurate only of the date of this live broadcast. Cognition undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this conference call.

With that, I would like to hand the call over to Lisa Ricciardi. Lisa?

Lisa Ricciardi